Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lactoferrin is a lipid A-binding protein

B J Appelmelk1, Y Q An, M Geerts

  • 1Department of Medical Microbiology, Vrije Universiteit, Amsterdam, The Netherlands.

Infection and Immunity
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The medical rehabilitation of the disabled.

International labour review·2010
Same author

The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction.

Cellular microbiology·2007
Same author

Routine pelvic lymphadenectomy in apparently early stage endometrial cancer.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2006
Same author

Long-term acid suppression by omeprazole in gastro-oesophageal reflux disease patients does not lead to anti-gastric autoantibody production.

Alimentary pharmacology & therapeutics·2005
Same author

An integrated approach for impact assessment of water harvesting techniques in dry areas: the case of oued Oum Zessar watershed (Tunisia).

Environmental monitoring and assessment·2005
Same author

[Recommendations for the management of women with an increased genetic risk of gynaecological cancer].

Nederlands tijdschrift voor geneeskunde·2003

Lactoferrin (LF) directly binds to bacterial lipopolysaccharides (LPS), explaining its antibacterial and anti-endotoxin effects. This interaction is crucial for understanding LF's role in combating Gram-negative bacterial infections.

Area of Science:

  • Biochemistry
  • Immunology
  • Microbiology

Background:

  • Lactoferrin (LF) exhibits antibacterial properties and modulates lipopolysaccharide (LPS)-induced immune responses.
  • The precise mechanism underlying LF's anti-endotoxic activity remains incompletely elucidated.

Purpose of the Study:

  • To investigate the direct binding interaction between Lactoferrin (LF) and lipopolysaccharides (LPS).
  • To elucidate the molecular mechanism of LF's antibacterial and anti-endotoxic effects.

Main Methods:

  • In vitro binding assays were performed using isolated lipid A and intact LPS from various bacterial species.
  • Binding inhibition studies were conducted using lipid A, polymyxin B, and KDO.
  • Ligand binding kinetics were analyzed to determine the affinity constant for the LF-lipid A interaction.

Related Experiment Videos

Main Results:

  • Lactoferrin (LF) demonstrated direct binding to lipid A and LPS from key Gram-negative pathogens like Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa.
  • Binding was specific, inhibited by lipid A and polymyxin B, but not by KDO.
  • A high affinity constant (2 x 10(9) M-1) was calculated for the LF-lipid A interaction, indicating a strong and saturable binding.

Conclusions:

  • The direct binding of LF to LPS, particularly lipid A, provides a mechanistic explanation for its antibacterial and anti-endotoxic activities.
  • Further in vitro and in vivo investigations are warranted to fully explore LF's potential in mitigating LPS-induced damage.